DK0923308T3 - Oprensning af biologisk aktive peptider fra mælk - Google Patents

Oprensning af biologisk aktive peptider fra mælk

Info

Publication number: DK0923308T3
Authority: DK; Denmark
Prior art keywords: milk; purification; biologically active; permeate; active peptides
Prior art date: 1996-05-13

Application number

DK97923643T

Other languages

Danish (da)

English (en)

Inventor

Joseph P Kutzko

Michael L Hayes

Lee T Sherman

Original Assignee

Genzyme Transgenics Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-05-13

Filing date

1997-05-13

Publication date

2002-10-14

1997-05-13 Application filed by Genzyme Transgenics Corp filed Critical Genzyme Transgenics Corp

2002-10-14 Application granted granted Critical

2002-10-14 Publication of DK0923308T3 publication Critical patent/DK0923308T3/da

Links

239000008267 milk Substances 0.000 title abstract 8
210000004080 milk Anatomy 0.000 title abstract 8
235000013336 milk Nutrition 0.000 title abstract 8
238000000746 purification Methods 0.000 title abstract 2
102000004196 processed proteins & peptides Human genes 0.000 title 1
108090000765 processed proteins & peptides Proteins 0.000 title 1
238000000034 method Methods 0.000 abstract 4
239000012466 permeate Substances 0.000 abstract 2
102000004169 proteins and genes Human genes 0.000 abstract 2
108090000623 proteins and genes Proteins 0.000 abstract 2
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 abstract 1
241001465754 Metazoa Species 0.000 abstract 1
239000002738 chelating agent Substances 0.000 abstract 1
238000009295 crossflow filtration Methods 0.000 abstract 1
239000012528 membrane Substances 0.000 abstract 1
239000012465 retentate Substances 0.000 abstract 1
230000001225 therapeutic effect Effects 0.000 abstract 1
230000009261 transgenic effect Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J1/00—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
- A23J1/20—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from milk, e.g. casein; from whey
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/832—Milk; colostrum

Landscapes

Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Biochemistry (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
Analytical Chemistry (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Health & Medical Sciences (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biophysics (AREA)
Engineering & Computer Science (AREA)
Food Science & Technology (AREA)
Polymers & Plastics (AREA)
Peptides Or Proteins (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

DK97923643T 1996-05-13 1997-05-13 Oprensning af biologisk aktive peptider fra mælk DK0923308T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US08/648,235 US6268487B1 (en)	1996-05-13	1996-05-13	Purification of biologically active peptides from milk
PCT/US1997/008044 WO1997042835A1 (fr)	1996-05-13	1997-05-13	Purification de peptides de lait, actifs du point de vue biologique

Publications (1)

Publication Number	Publication Date
DK0923308T3 true DK0923308T3 (da)	2002-10-14

Family

ID=24599969

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK97923643T DK0923308T3 (da)	1996-05-13	1997-05-13	Oprensning af biologisk aktive peptider fra mælk

Country Status (14)

Country	Link
US (1)	US6268487B1 (fr)
EP (1)	EP0923308B1 (fr)
JP (1)	JP4476362B2 (fr)
AT (1)	ATE224145T1 (fr)
AU (1)	AU725993B2 (fr)
CA (1)	CA2254871C (fr)
DE (2)	DE69715641T2 (fr)
DK (1)	DK0923308T3 (fr)
ES (1)	ES2182074T3 (fr)
LU (1)	LU91305I2 (fr)
NL (1)	NL300256I2 (fr)
NZ (1)	NZ332916A (fr)
PT (1)	PT923308E (fr)
WO (1)	WO1997042835A1 (fr)

Families Citing this family (71)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE122007000007I2 (de)	1986-04-09	2010-12-30	Genzyme Corp	Genetisch transformierte Tiere, die ein gewünschtes Protein in Milch absondern
EP1025244A2 (fr)	1997-10-20	2000-08-09	Genzyme Transgenics Corporation	SEQUENCES D'ACIDES NUCLEIQUES MSP-1 MODIFIES ET PROCEDES PERMETTANT D'ACCROITRE LES NIVEAUX D'ARNm ET L'EXPRESSION DES PROTEINES DANS LES SYSTEMES CELLULAIRES
SE9802213D0 (sv) *	1998-06-18	1998-06-18	Amersham Pharm Biotech Ab	A method for the removal/purification of serum albumins and means for use in the method
US20030005468A1 (en) *	1998-06-19	2003-01-02	Meade Harry M.	Methods and vectors for improving nucleic acid expression
DK1115745T3 (da) *	1998-09-24	2006-10-02	Pharming Intellectual Pty Bv	Oprensning af fibrinogen fra væsker ved udfældning og hydrofob interaktionskromatografi
CA2354638C (fr) *	1999-01-06	2013-03-19	Atlantic Biopharmaceuticals, Inc.	Expression d'alpha-foetoproteines humaines secretees chez des animaux transgeniques
EP1194570A1 (fr)	1999-06-23	2002-04-10	PPL Therapeutics (Scotland) Limited	Proteines de fusion incorporant un lysozyme
NZ522971A (en) *	2000-05-05	2005-02-25	Gtc Biotherapeutics Inc	Transgenically produced decorin in the mammary gland of a transgenic animal
US20020077775A1 (en) *	2000-05-25	2002-06-20	Schork Nicholas J.	Methods of DNA marker-based genetic analysis using estimated haplotype frequencies and uses thereof
US20030195707A1 (en) *	2000-05-25	2003-10-16	Schork Nicholas J	Methods of dna marker-based genetic analysis using estimated haplotype frequencies and uses thereof
US20040226053A1 (en) *	2000-10-13	2004-11-11	Meade Harry M.	Methods of producing a target molecule in a transgenic animal and purification of the target molecule
JP2004536081A (ja) *	2001-06-13	2004-12-02	トーラスエイチエスエイエルエルシー	ヒト血清アルブミンの精製
IL160229A0 (en) *	2001-08-10	2004-07-25	Genset Sa	Polynucleotides, polypeptides encoded thereby and their use
US6875459B2 (en) *	2001-09-10	2005-04-05	Henry B. Kopf	Method and apparatus for separation of milk, colostrum, and whey
US20060253913A1 (en) *	2001-12-21	2006-11-09	Yue-Jin Huang	Production of hSA-linked butyrylcholinesterases in transgenic mammals
AU2003247354A1 (en) *	2002-04-24	2003-11-10		Intermediate ingredient for dairy product manufacturing and method of making the same
EP1367065B1 (fr) *	2002-05-27	2008-07-30	Nestec S.A.	Protéines solubles dans l'acide obtenues à partir des micelles de caséine
GB0216001D0 (en) *	2002-07-10	2002-08-21	Nat Blood Authority	Process and composition
US20040092719A1 (en) *	2002-09-17	2004-05-13	Eszter Birck-Wilson	Isolation of immunoglobulin molecules that lack inter-heavy chain disulfide bonds
CA2506629A1 (fr) *	2002-11-27	2004-06-17	Gtc Biotherapeutics, Inc.	Production stable d'anticorps modifies dans le lait, et procedes de production
US20040210953A1 (en) *	2003-01-09	2004-10-21	Murray James D.	Lysozyme transgenic ungulates
US20040231010A1 (en) *	2003-01-09	2004-11-18	Murray James D.	Lysozyme transgenic ungulates
ES2371913T3 (es)	2003-01-22	2012-01-11	Duke University	Constructos mejorados para expresar polipéptidos lisosomales.
AU2003261387A1 (en) *	2003-02-24	2004-09-17	Gtc Biotherapeutics, Inc.	Methods of tangential flow filtration and an apparatus therefore
WO2005085287A1 (fr)	2004-03-03	2005-09-15	En-N-Tech, Inc.	Traitements pour la reduction de contaminants dans des preparations de lactoferrines et compositions contenant des lactoferrines
US20050197496A1 (en) *	2004-03-04	2005-09-08	Gtc Biotherapeutics, Inc.	Methods of protein fractionation using high performance tangential flow filtration
US20050245444A1 (en) *	2004-04-30	2005-11-03	Yann Echelard	Method of using recombinant human antithrombin for neurocognitive disorders
US20060121004A1 (en) *	2004-12-07	2006-06-08	Yann Echelard	Methods of reducing the incidence of rejection in tissue transplantation through the use of recombinant human antithrombin
US20060130159A1 (en) *	2004-12-09	2006-06-15	Nick Masiello	Method of purifying recombinant MSP 1-42 derived from Plasmodium falciparum
US20080019905A9 (en) *	2005-02-18	2008-01-24	Strome Scott E	Method of using an anti-CD137 antibody as an agent for radioimmunotherapy or radioimmunodetection
WO2006138647A2 (fr) *	2005-06-16	2006-12-28	Gtc Biotherapeutics, Inc.	Procede de fabrication d'anticorps humains de recombinaison destines a etre utilises dans la technologie des biocapteurs
WO2007014244A2 (fr) *	2005-07-25	2007-02-01	Gtc Biotherapeutics, Inc.	Procede de purification d'antithrombine humaine recombinante pour renforcer le profil de securite prionique et virale
KR20140133958A (ko) *	2005-10-21	2014-11-20	엘에프비 유에스에이, 인크.	항체 의존성 세포 독성 활성이 증강된 항체, 그 생산 및 사용 방법
US7531632B2 (en) *	2006-02-16	2009-05-12	Gtc Biotherapeutics, Inc.	Clarification of transgenic milk using depth filtration
FR2901707B1 (fr)	2006-05-31	2017-09-29	Lab Francais Du Fractionnement	Composition de facteur vii recombinant ou transgenique, chaque molecule de facteur vii possedant deux sites de n-glycosylation a motifs glycanniques definis
US20090208480A1 (en) *	2006-08-04	2009-08-20	Yue Huang	Long half-life recombinant butyrylcholinesterase
FR2910786B1 (fr) *	2006-12-29	2017-08-11	Laboratoire Francais Du Fractionnement Et Des Biotechnologies (Lfb)	"procede d'extraction d'une proteine presente dans du lait"
JP5208428B2 (ja) *	2007-01-30	2013-06-12	雪印メグミルク株式会社	美肌剤
FR2912310B1 (fr)	2007-02-13	2009-08-07	Kasan Sarl	Nouvelles compositions cosmetiques et/ou pharmaceutiques et leurs applications.
CA2696145C (fr)	2007-07-10	2016-12-20	Glanbia Nutritionals	Procede d'elimination d'endotoxines de proteines
TWI346666B (en) *	2007-12-31	2011-08-11	Animal Technology Inst Taiwan	Method for seperating casein from casein-contained solution
EP2077273B1 (fr)	2007-12-31	2011-09-14	Animal Technology Institute Taiwan	Procédés pour séparer la caséine de protéines solubles dans une composition
CN102014656B (zh) *	2008-04-21	2014-07-23	不二制油株式会社	脱脂豆乳肽的制备方法
EP2279003A4 (fr) *	2008-05-01	2013-04-03	Gtc Biotherapeutics Inc	Anticorps anti-cd137 en tant qu'agent dans le traitement d'états inflammatoires
NZ589311A (en) *	2008-05-14	2012-08-31	Agriculture Victoria Serv Pty	Angiogenin-enriched milk fractions prepared by methods involving heating the milk to over 70 degrees celsius for at least one minute
WO2011073235A1 (fr) *	2009-12-18	2011-06-23	Csl Ltd.	Procédé de purification de polypeptides
CA2784861A1 (fr)	2009-12-21	2011-07-14	Pharmathene, Inc.	Butyrylcholinesterases recombinantes et produits de troncature de ceux-ci
US8861162B2 (en) *	2010-03-09	2014-10-14	Honeywell International Inc.	High power solid state power controller (SSPC) solution for primary power distribution applications
US20110250264A1 (en)	2010-04-09	2011-10-13	Pacira Pharmaceuticals, Inc.	Method for formulating large diameter synthetic membrane vesicles
FR2958496A1 (fr) *	2010-04-09	2011-10-14	Bioprotein Technologies Sa	Preparation de proteine plasmatique de transfert des phospholipides (pltp) humaine recombinante a partir du lait d'animaux transgeniques.
EP2957628A1 (fr) *	2010-10-05	2015-12-23	Novo Nordisk Health Care AG	Procédé de production de protéine
ES2811526T3 (es)	2010-12-30	2021-03-12	Lab Francais Du Fractionnement	Glicoles como agentes de inactivación de patógenos
CN105413480B (zh)	2011-04-01	2019-03-29	Emd密理博公司	含有纳米纤维的复合材料结构
EP2729164A4 (fr) *	2011-07-07	2015-05-06	Lfb Usa Inc	Formulations stabilisant des protéines
TW201400499A (zh)	2012-03-12	2014-01-01	Revo Biolog Inc	抗凝血酶用於治療妊娠毒血症之用途
EP2687595B1 (fr)	2012-07-19	2018-05-30	Laboratoire Français du Fractionnement et des Biotechnologies	Procédé de purification de facteur VII transgénique
EP2879697A4 (fr)	2012-08-03	2016-01-20	Lfb Usa Inc	Utilisation d'antithrombine dans l'oxygénation de membrane extracorporelle
US10034921B2 (en)	2013-02-13	2018-07-31	Laboratoire Français Du Fractionnement Et Des Biotechnologies	Proteins with modified glycosylation and methods of production thereof
EP3594230A1 (fr)	2013-02-13	2020-01-15	Laboratoire Français du Fractionnement et des Biotechnologies	Anticorps anti-tnf alpha hautement galactosylés et leurs utilisations
EP3016729B1 (fr)	2013-07-05	2020-03-25	Laboratoire Francais du Fractionnement et des Biotechnologies Societe Anonyme	Matrice de chromatographie d'affinité
US9661868B2 (en) *	2013-07-16	2017-05-30	Mead Johnson Nutrition Company	Expanded bed adsorption methods for isolation of basic milk proteins including lactoferrin
KR20170040132A (ko) *	2014-06-02	2017-04-12	라보라토이레 프란카이즈 듀 프락티온네먼트 에트 데스 바이오테크놀로지스	Fc 단편의 제조
KR20190011838A (ko)	2014-06-26	2019-02-07	이엠디 밀리포어 코포레이션	개선된 먼지 포집 능력을 갖는 필터 구조
FR3034419B1 (fr)	2015-04-02	2017-12-15	Lab Francais Du Fractionnement	Procede de purification d'une proteine recombinante therapeutique a partir d'un lait transgenique
KR102206959B1 (ko) *	2015-04-17	2021-01-25	이엠디 밀리포어 코포레이션	접선방향 유동 여과 모드에서 작동되는 나노섬유 한외여과막을 사용하여 샘플에서 목적하는 생물학적 물질을 정제하는 방법
FR3038517B1 (fr)	2015-07-06	2020-02-28	Laboratoire Francais Du Fractionnement Et Des Biotechnologies	Utilisation de fragments fc modifies en immunotherapie
EP3655142B1 (fr)	2017-07-21	2026-02-25	Merck Millipore Ltd	Membranes de fibres non tissées
EP3805257A4 (fr) *	2018-05-24	2022-03-16	Jiangsu Hengrui Medicine Co., Ltd.	Procédé de préparation d'un précurseur d'insuline humaine recombinée ou d'un analogue associé
FR3082427B1 (fr)	2018-06-14	2020-09-25	Lab Francais Du Fractionnement	Combinaison de facteur vii et d'un anticorps bispecifique anti-facteurs ix et x
WO2022024828A1 (fr) *	2020-07-29	2022-02-03	和弘原	Dispositif de production d'une substance aux ingrédients ajustés et procédé de production d'une substance aux ingrédients ajustés
CN113101737B (zh) *	2021-03-04	2023-09-15	京美生命科技(杭州)有限公司	一种亲和切向流过滤系统及其构建方法和外泌体提取方法及应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2459619B1 (fr)	1979-06-26	1983-07-29	Agronomique Inst Nat Rech	Procede pour l'obtention a partir de lactoserum, d'un produit enrichi en alpha-lactalbumine et applications dudit procede
FR2487642B2 (fr)	1980-07-31	1985-10-18	Bel Fromageries	Procede de preparation de fractions proteiques par ultrafiltration et chromatographie d'exclusion et d'echange d'ions
DE3432718C1 (de)	1984-09-06	1986-05-22	Biotest Pharma GmbH, 6000 Frankfurt	Verfahren zur Herstellung einer Loesung von Milch- und/oder Kolostralimmunglobulinen
FR2584727B1 (fr)	1985-07-11	1988-06-17	Roussel Uclaf	Procede d'extraction de proteines du lait, produits, application du procede, et compositions pharmaceutiques
JPS62298536A (ja)	1986-06-17	1987-12-25	Green Cross Corp:The	生理活性物質の自動精製方法および自動精製装置
DE3743440A1 (de) *	1987-12-21	1989-06-29	Gauri Kailash Kumar	Verfahren zum trennen der geloesten und ungeloesten bestandteile von milch
US4897465A (en)	1988-10-12	1990-01-30	Abbott Laboratories	Enrichment and concentration of proteins by ultrafiltration
WO1993025567A1 (fr)	1992-06-15	1993-12-23	Gene Pharming Europe B.V.	Production de polypeptides recombines par des especes bovines et des procedes transgeniques
CA2351200A1 (fr)	1989-12-01	1991-06-13	Gene Pharming Europe Bv	Production de polypeptides recombinant par especes bovines et procedes transgeniques
NL9001650A (nl)	1990-07-19	1992-02-17	Ver Coop Melkind	Werkwijze voor de bereiding van een melkeiwit-isolaat.
US5256294A (en)	1990-09-17	1993-10-26	Genentech, Inc.	Tangential flow filtration process and apparatus
US5175013A (en)	1990-12-31	1992-12-29	The Pillsbury Company	Frozen dessert compositions and products
US5178894A (en)	1991-09-26	1993-01-12	Silvia P. Rudel	High non-fat milk content bread products having improved keeping qualities
US5256437A (en) *	1992-06-19	1993-10-26	Pall Corporation	Product and process of making sterile milk through dynamic microfiltration
WO1994019935A1 (fr)	1993-03-09	1994-09-15	Genzyme Corporation	Isolement de constituants d'interet du lait
EP0744901B1 (fr)	1994-02-16	2001-12-05	Pharming Intellectual Property BV	Isolation de la lactoferrine du lait
US5597486A (en) *	1995-05-01	1997-01-28	Millipore Investment Holdings Limited	Membrane filtration with optimized addition of second liquid to maximize flux

1996
- 1996-05-13 US US08/648,235 patent/US6268487B1/en not_active Expired - Lifetime
1997
- 1997-05-13 EP EP97923643A patent/EP0923308B1/fr not_active Expired - Lifetime
- 1997-05-13 AT AT97923643T patent/ATE224145T1/de active
- 1997-05-13 DE DE69715641T patent/DE69715641T2/de not_active Expired - Lifetime
- 1997-05-13 JP JP54103697A patent/JP4476362B2/ja not_active Expired - Lifetime
- 1997-05-13 WO PCT/US1997/008044 patent/WO1997042835A1/fr not_active Ceased
- 1997-05-13 DE DE122007000008C patent/DE122007000008I2/de active Active
- 1997-05-13 DK DK97923643T patent/DK0923308T3/da active
- 1997-05-13 CA CA002254871A patent/CA2254871C/fr not_active Expired - Lifetime
- 1997-05-13 PT PT97923643T patent/PT923308E/pt unknown
- 1997-05-13 AU AU29402/97A patent/AU725993B2/en not_active Expired
- 1997-05-13 ES ES97923643T patent/ES2182074T3/es not_active Expired - Lifetime
- 1997-05-13 NZ NZ332916A patent/NZ332916A/xx not_active IP Right Cessation
2007
- 2007-01-12 LU LU91305C patent/LU91305I2/fr unknown
- 2007-01-19 NL NL300256C patent/NL300256I2/nl unknown

Also Published As

Publication number	Publication date
US6268487B1 (en)	2001-07-31
AU2940297A (en)	1997-12-05
ATE224145T1 (de)	2002-10-15
LU91305I2 (fr)	2007-03-12
PT923308E (pt)	2002-11-29
CA2254871A1 (fr)	1997-11-20
CA2254871C (fr)	2008-03-25
NL300256I2 (nl)	2007-09-03
EP0923308B1 (fr)	2002-09-18
DE122007000008I2 (de)	2011-01-13
DE122007000008I1 (de)	2009-05-20
JP2000510701A (ja)	2000-08-22
EP0923308A4 (fr)	1999-06-30
DE69715641D1 (de)	2002-10-24
ES2182074T3 (es)	2003-03-01
DE69715641T2 (de)	2003-08-07
NZ332916A (en)	2000-05-26
NL300256I1 (nl)	2007-04-02
EP0923308A1 (fr)	1999-06-23
AU725993B2 (en)	2000-10-26
WO1997042835A1 (fr)	1997-11-20
JP4476362B2 (ja)	2010-06-09

Publication	Publication Date	Title
DK0923308T3 (da)	2002-10-14	Oprensning af biologisk aktive peptider fra mælk
ATE278785T1 (de)	2004-10-15	Neues verfahren zur gewinnung und reinigung von fusionsproteinen
DK0552192T3 (da)	1995-07-17	Forbedret tangentialstrømningsfiltreringsfremgangsmåde og -apparat
DE69400874D1 (de)	1996-12-12	Verfahren zur herstellung von keramischen hohlfasermembranen zur mikorfiltration, ultrafiltration und gastrennung
DK426386D0 (da)	1986-09-05	Fremgangsmaade til rensning og aktivering af proteiner fra uoploeselige inklusionslegemer
RU2007110534A (ru)	2008-10-20	Способ концентрирования препаратов антител
ATE310017T1 (de)	2005-12-15	Verfahren zur reinigung und isolierung von wasserlöslichen peptiden und proteinen aus pflanzenquellen
DK1200179T3 (da)	2006-09-25	Ladede filtreringsmembraner og anvendelser deraf
DE3774323D1 (de)	1991-12-12	Mikroporoese membran und verfahren zu ihrer herstellung.
DE3588254D1 (de)	2007-10-25	Gag-Antigen und dessen Verwendung zum Nachweis von LAV-Infektion, sowie in immunogenen Zusammensetzungen
DK0751988T3 (da)	2000-06-26	Højeffektiv fremstilling og isolering af virale partikler
ATE457823T1 (de)	2010-03-15	Membran zum filtrieren von wasser
DE58903874D1 (de)	1993-04-29	Integrale asymmetrische polyaethersulfonmembran, verfahren zur herstellung und verwendung zur ultrafiltration und mikrofiltration.
ATE204019T1 (de)	2001-08-15	Steigerung der transplantattoleranz durch schwein cytokine
DE69535314D1 (de)	2007-01-11	Modifizierte pflanzenviren als vektore für heterologe peptide
DK0764209T3 (da)	2001-03-19	Albuminekspression i gær
ATE279441T1 (de)	2004-10-15	Verfahren zur herstellung von genetisch veränderten lymphozyten vorläuferzellen von wirbeltieren und deren gebrauch zur produktion von heterologen bindeproteinen
UA35639C2 (uk)	2001-04-16	Спосіб одержання композиції очищеного капсидного білка вірусу папіломи людини
DE69908916D1 (de)	2003-07-24	Verfahren und vorrichtung zur behandlung von abwasser in einem bioreaktor, einer ultrafiltrationseinheit und einer membranfiltrationeinheit
ATE243067T1 (de)	2003-07-15	Verfahren zur hohlfasern filtration
TR200000899T2 (tr)	2000-07-21	Su arıtma cihazı ve metodu.
DE3871462D1 (de)	1992-07-02	Membran zur gastrennung.
DK0484464T3 (da)	1996-02-12	Fremgangsmåde til rensning af proteiner
NO971474L (no)	1997-06-03	Anti-inflammatorisk faktor, fremgangsmåte for isolering, og anvendelse
DE3786673D1 (de)	1993-08-26	Verfahren zur entfernung unerwuenschter zellen aus menschlichen lymphozytenpopulationen, anwendung des verfahrens zur herstellung monoklonaler antikoerper und dafuer geeigneter kit.